Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters









Database
Type of study
Language
Publication year range
1.
The new rHuEPO alpha (epotin) in the management of anemia of end-stage renal disease in patients on maintenance hemodialysis.
Abbas, E E; Afioni, N; Al Wakeel, J; Bakr, M A; Dham, R; Donia, A; Droubi, N; Khidir, E; Mathew, C M; Mitwali, A H; Naga, S; Pingle, A; Rashed, A; Roshdy, A; Shaheen, F; Shaibani, B; Shaibani, F M; Shaker, D S; Sheiban, A; Solieman, M.
Transplant Proc ; 36(6): 1805-11, 2004.
Article in English | MEDLINE | ID: mdl-15350482

ABSTRACT

Recombinant human erythropoietin has proved to be effective to treat anemia of end-stage renal disease (ESRD). The aim of this study was to assess the efficacy and safety profile of Epotin, a rHuEPO produced in the Middle East. One hundred thirty patients with Hct

Subject(s)
Anemia/drug therapy , Erythropoietin/therapeutic use , Hematinics/therapeutic use , Kidney Failure, Chronic/complications , Renal Dialysis , Adolescent , Adult , Anemia/etiology , Epoetin Alfa , Female , Ferritins/blood , Hematocrit , Humans , Iron/blood , Kidney Failure, Chronic/therapy , Male , Middle East , Recombinant Proteins
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL